Skip to content
The Joe Rogan ExperienceThe Joe Rogan Experience

Rick Perry & Hubbard on Joe Rogan: Why $100M on ibogaine

How veteran testimony drove Texas to fund $100M in ibogaine FDA trials; the drug claims to reset opioid and alcohol dependence in 48 to 72 hours.

Joe RoganhostRick PerryguestW. Bryan Hubbardguest
Apr 1, 20262h 14mWatch on YouTube ↗

CHAPTERS

  1. 0:02 – 4:57

    Texas commits $100M to the Ibogaine Initiative after a last-minute legislative push

    Bryan Hubbard recaps the whirlwind campaign in Texas to fund ibogaine drug development, culminating in an 11th-hour reversal. He confirms Texas will now fully fund the effort at $100M, framing it as the largest psychedelic research and medical development project to date.

  2. 4:57 – 6:52

    How Dan Patrick was persuaded: veterans’ testimonies, science, and a spiritual case

    Rogan asks what changed Lt. Gov. Dan Patrick’s mind. Hubbard explains that direct advocacy from veterans—especially Marcus and Morgan Luttrell—opened the door, after which the team presented ibogaine’s medical promise and transformative personal impact.

  3. 6:52 – 8:55

    Ibogaine 101: origins, history, and why it’s uniquely potent for addiction interruption

    Hubbard defines ibogaine, its botanical and cultural roots in Gabon, and its decades of field evidence. He describes its distinct ability to interrupt physiological dependence across multiple substances and possibly compulsive behaviors.

  4. 8:55 – 12:33

    Veterans, TBI, and neuroregeneration: Stanford findings and broader healing claims

    The discussion shifts to special operations veterans seeking ibogaine in Mexico for TBI-related depression, anxiety, and suicidality. Hubbard highlights Stanford’s early findings suggesting neuroregenerative effects and shares additional anecdotal reports across neurological conditions.

  5. 12:33 – 14:35

    Rick Perry’s personal motivation: Marcus Luttrell, suicide risk, and changing his worldview

    Perry explains he didn’t enter politics to champion psychedelics; he was drawn in by witnessing Marcus Luttrell’s suffering and near-suicide. He details years of trying conventional treatments and how ibogaine ultimately cleared opioid addiction in a way other interventions couldn’t.

  6. 14:35 – 24:11

    From “tough on crime” to reform—and from ‘Just Say No’ to ibogaine advocacy

    Perry draws parallels between his evolution on criminal justice reform and psychedelics. He argues anti-drug narratives were shaped by Nixon-era scheduling and decades of cultural messaging, despite ibogaine being non-addictive and non-recreational.

  7. 24:11 – 28:47

    Sponsor break and movement-building: Americans for Ibogaine scales nationwide

    After an ad read, the conversation returns to organizational growth. Perry and Hubbard describe Americans for Ibogaine’s expanding ambassador network and the strategy of building credibility, partnerships, and state-by-state political momentum.

  8. 28:47 – 35:42

    Why it works (and why it’s not ‘fun’): neuroplasticity windows, withdrawal interruption, and hard experiences

    Perry cites research comparisons across psychedelics’ ‘critical periods’ and notes ibogaine’s unusually long neuroplasticity window. Hubbard stresses ibogaine’s intensity and side effects, arguing its unpleasantness underscores it isn’t recreational while still being transformative for severe cases.

  9. 35:42 – 41:14

    Stories across society: trauma survivors, first responders, moral injury, CTE, and pro sports

    They share diverse case examples—from childhood sexual abuse recovery to first responders regaining careers, to moral injury relief, to athletes showing CTE-like symptoms. Rogan suggests connecting with the UFC, and they discuss head trauma in fighters and football players.

  10. 41:14 – 45:58

    Faith and psychedelics: Christian objections, scripture, and “A Christian’s Guide to Psychedelics”

    Perry addresses conservative Christian resistance and introduces an upcoming book reframing psychedelics through scripture and personal testimony. Rogan and Hubbard add examples of psychedelic interpretations in religious scholarship, emphasizing how cultural stigma—not evidence—shaped modern views.

  11. 45:58 – 53:56

    Spiritual famine, AI-era abundance, and psychedelics as social cohesion technology

    Hubbard broadens the lens: he argues modern America faces a spiritual crisis exploited by institutional power. He links forthcoming AI-driven abundance to the need for a spiritual reawakening, claiming psychedelics can help societies mature enough to handle transformative technologies.

  12. 53:56 – 56:08

    Curiosity, media narratives, and identity: why minds change (and why stereotypes persist)

    Rogan, Perry, and Hubbard explore how dogma blocks curiosity and how identity-based opinions hinder growth. They detour into stereotypes (including Southern accents) and the role of media in manufacturing division, emphasizing direct human contact over broadcast narratives.

  13. 56:08 – 1:33:21

    Scientific partnerships and Perry’s own ibogaine treatment: brain scans, atrophy reversal, and CTE concerns

    Perry reads a statement on a major collaboration with the Center for BrainHealth (UT Dallas) and partners to study ibogaine’s brain impact in veterans. He then recounts undergoing ibogaine himself for concussion-related anxiety/insomnia and describes striking changes in brain imaging, pivoting to Rogan’s concussion history and interest in treatment.

  14. 1:33:21 – 1:43:52

    Multi-state coalition and global/tribal expansion: bills, votes, Gabon partnership, and Native sovereignty questions

    Hubbard outlines a coordinated strategy to unite states behind a single FDA trial and lists legislative wins and active bills across the country. He also announces recognition by Gabon’s government and describes outreach to the Choctaw Nation and other tribes, prompting Rogan to ask whether tribal sovereignty could accelerate access.

  15. 1:43:52 – 1:57:53

    Regulatory choke points and the presidential ask: scheduling, Right-to-Try, and a 3-year ‘moonshot’

    They identify the DEA and federal bureaucracy as key obstacles, especially around Schedule I status and Right-to-Try interpretations. Hubbard lays out an explicit agenda for presidential action: rescheduling, directing agencies, and partnering with states to accelerate development.

  16. 1:57:53 – 2:07:30

    Kentucky origins and political grievance: town halls, trauma stories, and a sharp critique of Andy Beshear

    Hubbard recounts Kentucky opioid-abatement town halls that became public grief forums and shares a story linking childhood sexual abuse, medical opioids, and incarceration. He then launches into a pointed political critique of Kentucky Gov. Andy Beshear’s record and Purdue Pharma ties, arguing it exemplifies institutional failure that ibogaine could help rectify.

  17. 2:07:30 – 2:14:29

    Closing: a generational manifesto and a spiritual call to ‘bind up the brokenhearted’

    As they wrap, Hubbard delivers a sweeping statement about America’s crises—opioids, economic dispossession, and war-related suicide—framing ibogaine as a humanitarian and spiritual emancipation project. Rogan thanks them and ends the episode after Hubbard’s poetic final appeal.

Get more out of YouTube videos.

High quality summaries for YouTube videos. Accurate transcripts to search & find moments. Powered by ChatGPT & Claude AI.